Neil Willner
Neil M. Willner is an experienced cannabis attorney at Royer Cooper Cohen Braunfeld LLC and co-chair of the firm's Cannabis Group. He focuses his practice on the cannabis industry and provides counsel to hemp and marijuana companies across all parts of the supply chain on regulatory and compliance issues. Neil also participates on cannabis-related trade association committees including the New York State Bar Association’s Cannabis Law Section, the International Cannabis Bar Association, and the American Trade Association for Cannabis and Hemp (ATACH).
Education
- J. D., cum laude, New York Law School
- B.A., University of Vermont
Honors
- Best Lawyers Ones to Watch, 2024
- The Global Top 200 Cannabis Lawyers, 2022-Present
- Chambers USA Associate to Watch
Professional Accomplishments
- Co-authored a chapter in the 2020 edition of the Thomson Reuters Health Law Handbook
- Co-authored a chapter in the American Health Law Association’s Health Care and the Business of Cannabis Questions and Answers book
- Co-authored an Amicus brief on behalf of the National Cannabis Industry Association (NCIA) for a writ of certiorari to the Supreme Court in the case of Washington v. Barr
- Has been quoted in articles published by the New York Times, the Village Voice, Forbes, and Lawyer.com
Affiliations
- Co-chair of Cannabis Group, Royer Cooper Cohen Braunfeld LLC
- Executive Committee, New York State Bar Association’s Cannabis Law Section
- Member of the Online Content Committee, International Cannabis Bar Association
- Regulatory Counsel, American Trade Association for Cannabis and Hemp (ATACH)
- Co-chair, Cannabis Committee for the Claims and Litigation Management Alliance (CLM)
CBD Oracle Editorial Guidelines
CBD Oracle’s primary mission is to provide accurate, evidence-based information. The CBD Oracle Medical Advisory Board and expert reviewers ensure that every article on our platform is factual and well-sourced. Medical and legal content on CBD Oracle is independently reviewed by a qualified expert in a relevant field prior to publishing and before any major revisions, with a focus on accuracy and reliability. Read more about our editorial guidelines.